Process for the preparation of 17-phenyl-18,19,20-thinor-pgf 2a and its derivatives
AssigneeFinetech Laboratories Ltd.
InventorsArie Gutman, Gennady Nisnevich, Marina Etinger, Igor Zaltzman, Lev Yudovitch, Boris Pertsikov
Life of this patent
Estimating the term…
Abstract
The present invention provides a new and effective process for the synthesis of 17-phenyl-18,19,20-trinor-PGF2α and its derivatives, including the anti-glaucoma drugs Bimatoprost and Latanoprost. The benefit of the present invention rises inter alia from the fact that a major intermediate involved in the synthesis of the above compounds may be isolated from a mixture containing also an undesired isomer, by crystallization. In addition, the undesired isomer may be oxidized to give the starting compound, which is then recycled.
Claims22
A process for the preparation of 17-phenyl-18,19,20-trinor-PGF2α and its derivatives of Formula [1b]
- 37
- wherein
- the bond between carbons 1 and 2 is either a single bond (C1—C2) or a double bond (C1═C2), and
- R6 is selected from the group consisting of alkoxy and alkylamino;
- such process comprising:
- (a) stereoselective reduction of the carbonyl group of the compound [4]
- 38
- to yield a mixture of compounds of formulae [5a] and [6a],
- 39
- where [5a] is the predominant isomer, which are subsequently converted into a mixture of compounds of formulae [5] (C1═C2) and [6]:
- 40
- followed by isolation of the compound [5] (C1═C2) from the mixture and, if desired, hydrogenation of the double bond C1═C2 between carbons 1 and 2 of the compound [5] (C1═C2) in the presence of a catalyst to give the compound [5] (C1—C2) where the bond between carbons 1 and 2 is a single bond;
- where one of R1 and R2 is an arylcarbonyl group and the other one is selected from the group consisting of arylcarbonyl, acyl, trialkylsilyl, dialkylarylsilyl, 1-alkoxyalkyl, unsubstituted and alkyl-substituted tetrahydro-2H-pyran-2-yl and tetrahydrofuran-2-yl;
- (b) converting compound [6] from the mother liquor of step (a) into compound [6a], oxidizing the hydroxyl group of the compound [6a] to yield the compound [4] and recycling the compound [4] to step (a);
- (c) reducing the compound [5] with diisobutylaluminum hydride at a temperature range from −20 to +20° C. followed by hydrolysis of the obtained reaction mixture under basic conditions to give the compound [11],
- 41
- wherein the bond between carbons 1 and 2 is either a single bond (C1—C2) or a double bond (C1═C2);
- R3 is hydrogen when R1 is acyl and is equal to R1 when it is trialkylsilyl, dialkylarylsilyl, 1-alkoxyalkyl, unsubstituted or alkyl-substituted tetrahydro-2H-pyran-2-yl or tetrahydrofuran-2-yl;
- R4 is hydrogen when R2 is acyl and is equal to R2 when it is trialkylsilyl, dialkylarylsilyl, 1-alkoxyalkyl, unsubstituted or alkyl-substituted tetrahydro-2H-pyran-2-yl or tetrahydrofuran-2-yl and
- (d) reacting compound [11] with a metal salt of 5-(triphenylphosphoranylidene)pentanoic acid, to obtain the compound of formula [1a]
- 42
- and
- (e) deriving the carboxyl group of the compound [1a], optionally, after deprotecting the hydroxyl groups, to give the desired compound [1b].
Compound of the formula [5]:
- 43
- wherein
- the bond between carbons 1 and 2 is either a single bond (C1—C2) or a double bond (C1═C2), R1 is p-phenylbenzoyl (PPB) group and R2 is tetrahydro-2H-pyran-2-yl (THP) group.
A process for the preparation of a 15(S)-prostaglandin intermediate compound of the formula (5):
- 44
- which comprises reducing a compound of the formula (4):
- 45
- wherein:
- R1 is an aryl carbonyl group.
A process for the preparation of a 15(S)-prostaglandin intermediate compound of the formula (5):
- 46
- which comprises the steps of:
- (a) reducing a compound of the formula (4):
- 47
- wherein:
- R1 is an aryl carbonyl group;
- and
- (b) quenching said reduction step.
A process for the preparation of a 15(S)-prostaglandin intermediate of a compound of the formula (5):
- 48
- which comprises the steps of:
- (a) reducing a compound of the formula (4):
- 49
- with (−)-chlorodiisopinocampheylborane while maintaining a reaction mixture temperature in the range of from about −23° C. to about −250° C., wherein:
- R1 is an aryl carbonyl group;
- and
- (b) quenching said reduction step with a boron complexing agent.
Dependencies are inferred from the claim text.